Skip to content

Clinical trials

Observational Anxiety Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Observational Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20171
20181
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Australian and New Zealand Intensive Care Research Centre1
Bayside Health1
Philip Moons1
The University of New South Wales1
University of Chile1
University of Social Sciences and Humanities, Warsaw1
Żelazna Medical Centre, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders7
COVID-193
Mental Disorders2
Attention Deficit and Disruptive Behavior Disorders1
Coronavirus Infections1
Critical Illness1
Cystic Fibrosis1
Heart Defects, Congenital1
Mood Disorders1
Psychotic Disorders1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.